CANCER

Dec 15 2024HEALTH

How England's Health System Handles Cancer with Vague Symptoms

Have you ever wondered how doctors figure out if you have cancer when you don't have clear symptoms? In England, the National Health Service (NHS) has a special way to handle this. Researchers decided to take a close look at how these rules, called non-specific symptom pathways, are being used. They

reading time less than a minute
Dec 14 2024SCIENCE

Unraveling MYC's Mysteries: Decoding Genetic Variants

Imagine a tiny part of our DNA that's like a supervisor in a busy factory, telling cells what to do. This is the MYC gene, and it's crucial for cells to grow, change, and even keep our immune system on guard. But sometimes, this supervisor can go rogue, causing trouble in over 70% of human cancers.

reading time less than a minute
Dec 14 2024HEALTH

Unraveling Ovarian Cancer: How Medical Images Help

Ovarian cancer is one of the most fatal gynecological cancers worldwide. While medical imaging is used to screen for ovarian cancer, accurately identifying whether a tumor is benign or malignant is still challenging. This is because the images can vary, making it hard to get objective results withou

reading time less than a minute
Dec 14 2024HEALTH

Timing BCG Treatment After Bladder Surgery: Does It Matter?

You might be wondering if the timing of BCG treatment after bladder tumor removal affects how well it works. BCG, which stands for Bacillus Calmette-Guerin, is a common treatment for non-muscle invasive bladder cancer (NMIBC). Doctors often use a procedure called transurethral resection of bladder t

reading time less than a minute
Dec 14 2024HEALTH

Imaging EBV-Positive Nasopharyngeal Cancer: 68Ga-DOTATATE vs. 18F-FDG PET/CT

Nasopharyngeal carcinoma, a type of cancer prevalent in certain regions, has a strong link to the Epstein-Barr virus (EBV). This study wanted to find out which imaging method, 68Ga-DOTATATE PET/CT or 18F-FDG PET/CT, was better for detecting and managing EBV-positive nonkeratinizing nasopharyngeal ca

reading time less than a minute
Dec 14 2024HEALTH

Understanding Breast Cancer: The Role of Deubiquitinating Enzymes

Breast cancer is one of the most common cancers among women, and it comes in many different forms. This makes it tricky to diagnose and treat. One important process in our cells is called ubiquitination, which helps regulate many things like the cell cycle, DNA repair, and more. Deubiquitinating enz

reading time less than a minute
Dec 14 2024HEALTH

How Sericin and Hydroxychloroquine Team Up to Fight Lung Cancer in Mice

There's an interesting team-up happening in the world of science. Researchers found that sericin and hydroxychloroquine (HQ) can work together to reduce lung damage and even prevent early stages of lung cancer in mice. This duo targets a specific pathway in the body called PI3K/Akt/Nrf2/NF-κB. By ta

reading time less than a minute
Dec 14 2024HEALTH

Revamping Cancer Detection: How Holograms and AI Team Up

Medical imaging plays a big role in catching diseases early. Traditional methods like MRI, CT scans, ultrasounds, and PET scans show us the insides of our bodies in 3D, but they often miss little details that could be crucial. This is where holography microscopic imaging comes in handy. It doesn't j

reading time less than a minute
Dec 14 2024HEALTH

Fighting TNBC: A New Hope Called Compound 43

Breast cancer comes in many forms, and one of the toughest types is Triple-Negative Breast Cancer (TNBC). This type of cancer doesn't have the usual targets that treatments often go for, making it tricky to treat. Scientists have been trying something clever though. They've been using a method calle

reading time less than a minute
Dec 13 2024SCIENCE

Smart Nanoparticles in Cancer Fight: Where We Stand

Over the past few years, tiny nanoparticles made from special polymers have caught the eye of researchers and doctors for treating cancer. These smart particles can deliver medicine right where it's needed in the body. However, while many amazing ideas have come up in labs, not many have made it to

reading time less than a minute